The association of chronic cough with the risk of myocardial infarction: The Framingham Heart Study

American Journal of Medicine

Volumn 106, Issue 3, 1999, Pages 279-284

  Haider, Agha W ^a,b,c   Larson, Martin G ^a,b   O'Donnell, Christopher J ^a,d   Evans, Jane C ^b   Wilson, Peter W F ^a   Levy, Daniel ^a,b,e  

^a Natl Heart Lung/Blood Institute   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC LUNG DISEASE; CIGARETTE SMOKING; COUGHING; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COUGH; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; RISK; RISK FACTORS; SMOKING;

EID: 0033106324     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00027-3     Document Type: Article

References (52)

1. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
2. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850.
3. Ridker P.M., Cushman M.J., Stampfer M.J., et al. Inflammation, aspirin and risk of cardiovascular disease in apparently healthy men. NEJM. 336:1997;973-979.
4. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. NEJM. 331:1994;417-424.
5. Thompson S.G., Kienast J., Pyke S.D., et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. NEJM. 332:1995;635-641.
6. Ridker P.M., Hennekens C.H., Roitman-Johnson B., et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 351:1998;88-92.
7. Mendall M.A., Patel P., Ballam L., et al. C reactive protein and its relation to cardiovascular risk factors a population based cross sectional study . BMJ. 312:1996;1061-1065.
8. Kuller L.H., Tracy R.P., Shaten J., Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 144:1996;537-547.
9. Tracy R.P., Lemaitre R.N., Psaty B.M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 17:1997;1121-1127.
10. Meier C.R., Jick S.S., Derby L.E., et al. Acute respiratory tract infections and risk of first-time acute myocardial infarction. Lancet. 351:1998;1467-1471.
11. Nieminen M.S., Mattila K., Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J. 14:(suppl K):1993;12-16.
12. Mattila K.J., Valle M.S., Nieminen M.S., et al. Dental infections and coronary atherosclerosis. Atherosclerosis. 103:1993;205-211.
13. Epstein S.E., Speir E., Zhou Y.F., et al. The role of infection in restenosis and atherosclerosis focus on cytomegalovirus . Lancet. 348:(suppl 1):1996;S13-S17.
14. Cook P.J., Lip G.Y. Infectious agents and atherosclerotic vascular disease. QJM. 89:1996;727-735.
15. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease is there a link? Lancet. 350:1997;430-436.
16. Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis an assessment of the evidence and need for future research . Circulation. 96:1997;4095-4103.
17. Saikku P., Leinonen M., Tenkanen L., et al. Chronic chlamydia pneumoniae infection as a risk factor for coronary heart disease in the helsinki heart study. Ann Intern Med. 116:1992;273-278.
18. Patel P., Mendall M.A., Carrington D., et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 311:1995;711-714.
19. Zhou Y.F., Leon M.B., Waclawiw M.A., et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. NEJM. 335:1996;624-630.
20. Blasi F., Cosentini R., Raccanelli R., et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest. 112:1997;309-312.
21. Nieto F.J., Adam E., Sorlie P., et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 94:1996;922-927.
22. Maseri A. Inflammation, atherosclerosis, and ischemic events - exploring the hidden side of the moon. NEJM. 336:1997;1014-1016.
23. Ingram R.H.J. Chronic bronchitis, ephysema, and airways obstruction. Isselbacher K.J., Braunwald E., Wilson J.D., et al. Harrison's Principles of Internal Medicine. 13th ed. 1994;1197-1206 McGraw-Hill, New York.
24. Spodick D.H., Flessas A.P., Johnson M.M. Association of acute respiratory symptoms with onset of acute myocardial infarction prospective investigation of 150 consecutive patients and matched control patients . Am J Cardiol. 53:1984;481-482.
25. Jousilahti P., Vartiainen E., Tuomilehto J., Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 348:1996;567-572.
26. Grau A.J., Buggle F., Ziegler C., et al. Association between acute cerebrovascular ischemia and chronic and recurrent infection. Stroke. 28:1997;1724-1729.
27. Dawber T.R., Meadors G.F., Moore F.E.J. Epidemiological approaches to heart disease the Framingham Study . Am J Public Health. 41:1997;279-286.
28. Kannel WB, Wolf P, Garrison RJ. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Section 34: some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements Framingham Heart Study, 30 year follow-up. Bethesda: National Institute of Health, PB87-177499; 1988.
29. Abell L.L., Levy B.B., Brodie B.B., Kendall F.E. Simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 195:1952;357-366.
30. Kannel W.B., Wolf P.A., Castelli W.P., D'Agostino R.B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 258:1987;1183-1186.
31. D'Agostino R.B., Lee M.L., Belanger A.J., et al. Relation of pooled logistic regression to time dependent Cox regression analysis the Framingham Heart Study . Stat Med. 9:1990;1501-1515.
32. Hosmer D.W., Lemeshow S. Applied Logistic Regression. 1989;Wiley & Sons, New York.
33. Kleinbaum D.G., Kupper L.L., Muller K.E. Applied Regression Analysis and Other Multivariable Methods. 1989;PWS-Kent, Boston.
34. SAS/STAT Software Changes and Enhancements through Release 6.11 . 6.11 ed. 1996;SAS Institute, Inc, Cary, NC.
35. SAS/STAT User's Guide, Version 6. 4th ed. 1989;SAS Institute Inc, Cary, NC.
36. Ashley F., Kannel W.B., Sorlie P.D., Masson R. Pulmonary function relation to aging, cigarette habit, and mortality . Ann Intern Med. 82:1975;739-745.
37. Friedman G.D., Klatsky A.L., Siegelaub A.B. Lung function and risk of myocardial infarction and sudden cardiac death. NEJM. 294:1976;1071-1075.
38. Krzyzanowski M., Wysocki A.L. The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms the Cracow Study . Int J Epidemiol. 15:1986;56-64.
39. Vallance P., Collier J., Bhagat K. Infection, inflammation, and infarction does acute endothelial dysfunction provide a link? Lancet. 349:1997;1391-1392.
40. Laurila A., Bloigu A., Nayha S., et al. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;2910-2913.
41. Sammalkorpi K. Glucose intolerance in acute infections. J Intern Med. 225:1989;15-19.
42. Saikku P., Leinonen M., Mattila K., et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
43. Gupta S., Leatham E.W., Carrington D., et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407.
44. Wimmer M.L., Sandmann-Strupp R., Saikku P., Haberl R.L. Association of chlamydial infection with cerebrovascular disease. Stroke. 27:1996;2207-2210.
45. Mendall M.A., Carrington D., Strachan D., et al. Chlamydia pneumoniae risk factors for seropositivity and association with coronary heart disease . J Infect. 30:1995;121-128.
46. Muhlestein J.B., Hammond E.H., Carlquist J.F., et al. Increased incidence of chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 27:1996;1555-1561.
47. Rimm E.B., Stampfer M.J., Ascherio A., et al. Vitamin E consumption and the risk of coronary heart disease in men. NEJM. 328:1993;1450-1456.
48. Khaw K.T., Woodhouse P. Interrelation of vitamin C, infection, haemostatic factors, and cardiovascular disease. BMJ. 310:1995;1559-1563.
49. Kannel W.B., Anderson K., Wilson P.W. White blood cell count and cardiovascular disease. Insights from the Framingham study. JAMA. 267:1992;1253-1256.
50. Yarnell J.W., Baker I.A., Sweetnam P.M., et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation. 83:1991;836-844.
51. Meade T.W., Mellows S., Brozovic M., et al. Haemostatic function and ischaemic heart disease principal results of the Northwick Park Heart Study . Lancet. 2:1986;533-537.
52. Gurfinkel E., Bozovich G., Daroca A., et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. ROXIS Study Group. Lancet. 350:1997;404-407.